ABSCI CORP (ABSI) Fundamental Analysis & Valuation
NASDAQ:ABSI • US00091E1091
Current stock price
3.94 USD
-0.03 (-0.76%)
At close:
3.9148 USD
-0.03 (-0.64%)
After Hours:
This ABSI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ABSI Profitability Analysis
1.1 Basic Checks
- In the past year ABSI has reported negative net income.
- ABSI had a negative operating cash flow in the past year.
- ABSI had negative earnings in each of the past 5 years.
- In the past 5 years ABSI always reported negative operating cash flow.
1.2 Ratios
- ABSI's Return On Assets of -53.25% is in line compared to the rest of the industry. ABSI outperforms 44.57% of its industry peers.
- ABSI has a Return On Equity of -60.80%. This is comparable to the rest of the industry: ABSI outperforms 56.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -53.25% | ||
| ROE | -60.8% | ||
| ROIC | N/A |
ROA(3y)-50.8%
ROA(5y)-41.86%
ROE(3y)-60.37%
ROE(5y)-49.51%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- ABSI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. ABSI Health Analysis
2.1 Basic Checks
- ABSI does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, ABSI has more shares outstanding
- The number of shares outstanding for ABSI has been increased compared to 5 years ago.
- ABSI has a better debt/assets ratio than last year.
2.2 Solvency
- ABSI has an Altman-Z score of 8.23. This indicates that ABSI is financially healthy and has little risk of bankruptcy at the moment.
- ABSI's Altman-Z score of 8.23 is fine compared to the rest of the industry. ABSI outperforms 78.68% of its industry peers.
- There is no outstanding debt for ABSI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 8.23 |
ROIC/WACCN/A
WACC9.41%
2.3 Liquidity
- A Current Ratio of 6.57 indicates that ABSI has no problem at all paying its short term obligations.
- With a decent Current ratio value of 6.57, ABSI is doing good in the industry, outperforming 64.92% of the companies in the same industry.
- ABSI has a Quick Ratio of 6.57. This indicates that ABSI is financially healthy and has no problem in meeting its short term obligations.
- The Quick ratio of ABSI (6.57) is better than 65.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.57 | ||
| Quick Ratio | 6.57 |
3. ABSI Growth Analysis
3.1 Past
- ABSI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.60%, which is quite good.
- ABSI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -38.24%.
- The Revenue for ABSI have been decreasing by -10.14% on average. This is quite bad
EPS 1Y (TTM)8.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
Revenue 1Y (TTM)-38.24%
Revenue growth 3Y-21.33%
Revenue growth 5Y-10.14%
Sales Q2Q%-2.26%
3.2 Future
- ABSI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.60% yearly.
- The Revenue is expected to grow by 92.38% on average over the next years. This is a very strong growth
EPS Next Y1.26%
EPS Next 2Y11.43%
EPS Next 3Y11.71%
EPS Next 5Y13.6%
Revenue Next Year76.24%
Revenue Next 2Y171.77%
Revenue Next 3Y130.02%
Revenue Next 5Y92.38%
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. ABSI Valuation Analysis
4.1 Price/Earnings Ratio
- ABSI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ABSI. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.43%
EPS Next 3Y11.71%
5. ABSI Dividend Analysis
5.1 Amount
- No dividends for ABSI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ABSI Fundamentals: All Metrics, Ratios and Statistics
3.94
-0.03 (-0.76%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-24 2026-03-24/amc
Earnings (Next)05-07 2026-05-07
Inst Owners76.34%
Inst Owner Change0.13%
Ins Owners6.57%
Ins Owner Change3.12%
Market Cap602.90M
Revenue(TTM)2.80M
Net Income(TTM)-115.18M
Analysts81.33
Price Target8.19 (107.87%)
Short Float %28.22%
Short Ratio10.3
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.22%
Min EPS beat(2)-0.92%
Max EPS beat(2)7.37%
EPS beat(4)2
Avg EPS beat(4)1.49%
Min EPS beat(4)-10.99%
Max EPS beat(4)10.49%
EPS beat(8)2
Avg EPS beat(8)-2.78%
EPS beat(12)2
Avg EPS beat(12)-9.53%
EPS beat(16)3
Avg EPS beat(16)-7.41%
Revenue beat(2)0
Avg Revenue beat(2)-59.76%
Min Revenue beat(2)-77.45%
Max Revenue beat(2)-42.07%
Revenue beat(4)0
Avg Revenue beat(4)-46.57%
Min Revenue beat(4)-77.45%
Max Revenue beat(4)-12.08%
Revenue beat(8)0
Avg Revenue beat(8)-43.41%
Revenue beat(12)1
Avg Revenue beat(12)-41.72%
Revenue beat(16)2
Avg Revenue beat(16)-40.25%
PT rev (1m)-0.21%
PT rev (3m)-0.21%
EPS NQ rev (1m)-16.67%
EPS NQ rev (3m)-16.67%
EPS NY rev (1m)-17.79%
EPS NY rev (3m)-17.79%
Revenue NQ rev (1m)-24.94%
Revenue NQ rev (3m)-24.94%
Revenue NY rev (1m)-57.34%
Revenue NY rev (3m)-57.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 215.32 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 3.18 | ||
| P/tB | 4.08 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.85
EYN/A
EPS(NY)-0.84
Fwd EYN/A
FCF(TTM)-0.61
FCFYN/A
OCF(TTM)-0.61
OCFYN/A
SpS0.02
BVpS1.24
TBVpS0.97
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -53.25% | ||
| ROE | -60.8% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-50.8%
ROA(5y)-41.86%
ROE(3y)-60.37%
ROE(5y)-49.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.01
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 9.43% | ||
| Cap/Sales | 39.54% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 6.57 | ||
| Quick Ratio | 6.57 | ||
| Altman-Z | 8.23 |
F-Score3
WACC9.41%
ROIC/WACCN/A
Cap/Depr(3y)6.2%
Cap/Depr(5y)142.97%
Cap/Sales(3y)21.16%
Cap/Sales(5y)228.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
EPS Next Y1.26%
EPS Next 2Y11.43%
EPS Next 3Y11.71%
EPS Next 5Y13.6%
Revenue 1Y (TTM)-38.24%
Revenue growth 3Y-21.33%
Revenue growth 5Y-10.14%
Sales Q2Q%-2.26%
Revenue Next Year76.24%
Revenue Next 2Y171.77%
Revenue Next 3Y130.02%
Revenue Next 5Y92.38%
EBIT growth 1Y-16.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year5.36%
EBIT Next 3Y3.74%
EBIT Next 5Y-0.65%
FCF growth 1Y-29.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-28.35%
OCF growth 3YN/A
OCF growth 5YN/A
ABSCI CORP / ABSI Fundamental Analysis FAQ
What is the ChartMill fundamental rating of ABSCI CORP (ABSI) stock?
ChartMill assigns a fundamental rating of 3 / 10 to ABSI.
What is the valuation status of ABSCI CORP (ABSI) stock?
ChartMill assigns a valuation rating of 0 / 10 to ABSCI CORP (ABSI). This can be considered as Overvalued.
Can you provide the profitability details for ABSCI CORP?
ABSCI CORP (ABSI) has a profitability rating of 1 / 10.